Liquid Biopsy Market (By Application: Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancer, Molecular Health Monitoring; By Sample Type: Blood Sample based, Urine Sample based, Other Bio Fluids based; By Biomarker: Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes; By End-use: Multi-gene-parallel Analysis (NGS), Single Gene Analysis) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Oct 2021 | No. of Pages : 150+ Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Biomarker Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Liquid Biopsy Market, By Application

7.1.  Liquid Biopsy Market, by Application, 2021-2030

7.1.1.    Therapy Selection for Metastatic Breast Cancer (MBS)

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Therapy Selection for Other Metastatic Cancer

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Molecular Health Monitoring

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Liquid Biopsy Market, By Sample Type

8.1.  Liquid Biopsy Market, by Sample Type, 2021-2030

8.1.1.    Blood Sample based

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Urine Sample based

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Other Bio Fluids (Tissue fluids and Saliva) based

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Liquid Biopsy Market, By Biomarker

9.1.  Liquid Biopsy Market, by Biomarker, 2021-2030

9.1.1.    Circulating Tumor Cells (CTC)

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Circulating Tumor DNA (ctDNA)

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Exosomes

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Liquid Biopsy Market, By Technology

10.1.        Liquid Biopsy Market, by Technology, 2021-2030

10.1.1.  Multi-gene-parallel Analysis (NGS)

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Single Gene Analysis (PCR Microarrays)

10.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Liquid Biopsy Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Application (2017-2030)

11.1.2.  Market Revenue and Forecast, by Sample Type (2017-2030)

11.1.3.  Market Revenue and Forecast, by Biomarker (2017-2030)

11.1.4.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Application (2017-2030)

11.2.2.  Market Revenue and Forecast, by Sample Type (2017-2030)

11.2.3.  Market Revenue and Forecast, by Biomarker (2017-2030)

11.2.4.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Application (2017-2030)

11.3.2.  Market Revenue and Forecast, by Sample Type (2017-2030)

11.3.3.  Market Revenue and Forecast, by Biomarker (2017-2030)

11.3.4.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Application (2017-2030)

11.4.2.  Market Revenue and Forecast, by Sample Type (2017-2030)

11.4.3.  Market Revenue and Forecast, by Biomarker (2017-2030)

11.4.4.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Application (2017-2030)

11.5.2.  Market Revenue and Forecast, by Sample Type (2017-2030)

11.5.3.  Market Revenue and Forecast, by Biomarker (2017-2030)

11.5.4.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Sample Type (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Biomarker (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by Technology (2017-2030)

Chapter 12.  Company Profiles

12.1.              Guardant Health

12.1.1.  Company Overview

12.1.2.  Application Offerings

12.1.3.  Financial PerSample Typeance

12.1.4.  Recent Initiatives

12.2.              Personal Genome Diagnostics

12.2.1.  Company Overview

12.2.2.  Application Offerings

12.2.3.  Financial PerSample Typeance

12.2.4.  Recent Initiatives

12.3.              Biocept

12.3.1.  Company Overview

12.3.2.  Application Offerings

12.3.3.  Financial PerSample Typeance

12.3.4.  Recent Initiatives

12.4.              Adaptive Biotechnologies

12.4.1.  Company Overview

12.4.2.  Application Offerings

12.4.3.  Financial PerSample Typeance

12.4.4.  Recent Initiatives

12.5.              Cynvenio

12.5.1.  Company Overview

12.5.2.  Application Offerings

12.5.3.  Financial PerSample Typeance

12.5.4.  Recent Initiatives

12.6.              NeoGenomics Laboratories

12.6.1.  Company Overview

12.6.2.  Application Offerings

12.6.3.  Financial PerSample Typeance

12.6.4.  Recent Initiatives

12.7.              Qiagen

12.7.1.  Company Overview

12.7.2.  Application Offerings

12.7.3.  Financial PerSample Typeance

12.7.4.  Recent Initiatives

12.8.              Trovagene

12.8.1.  Company Overview

12.8.2.  Application Offerings

12.8.3.  Financial PerSample Typeance

12.8.4.  Recent Initiatives

12.9.              RainDance Technologies

12.9.1.  Company Overview

12.9.2.  Application Offerings

12.9.3.  Financial PerSample Typeance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Medical Digital Imaging Systems Market (By Type: X-ray, MRI, Ultrasound, CT, Nuclear Imaging; By Technology: 2D, 3D/4D) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030

    Read more...